Rare Disease Market Access Consulting Firm Alkemi Ranks No. 395 on the 2023 Inc. 5000

With Three-Year Revenue Growth of 1,467 Percent, Vermont based Alkemi Ranks No. 395 Among America's Fastest-Growing Private Companies. The rapidly growing rare disease market, coupled with the extraordinary need for deep expertise, propels Alkemi's remarkable growth! MANCHESTER CENTER, Vt....
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: AWD SVY Source Type: news